CLL: Ibrutinib-/Venetoclax-Kombination mit limitierter Dauer...
Deutsches Ärzteblatt,
/picture-alliance, Dr.med.J.P.Mller Alexandria Bei der chronischen lymphatischen Leukmie (CLL) werden in letzter Zeit immer…
Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication
Overview of attention for article published in Blood Cancer Journal, February 2021
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (88th percentile)
-
Good Attention Score compared to outputs of the same age and source (79th percentile)
Readers on
- mendeley
- 45 Mendeley
